Announcements Trials
Browse Landscape

Status

Available 2No longer available 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 384Observational 43Expanded_access 3

Sponsor

Cancer Type

Myeloid 3Lymphoid 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Gynecologic 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Primary Myelofibrosis 3Lymphoma 3Leukemia 3Hematologic Neoplasms 3Blast Crisis 3Precancerous Conditions 2Polycythemia Vera 2Multiple Myeloma 2Mastocytosis, Systemic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Mast-Cell 2Immunologic Deficiency Syndromes 2Graft vs Host Disease 2Waldenstrom Macroglobulinemia 1Thalassemia 1Sarcoma 1Recurrence 1Preleukemia 1Pancytopenia 1Osteosclerosis 1Osteopetrosis 1Osteochondrodysplasias 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Neoplasms 1

Interventions

venetoclax 1selinexor 1ruxolitinib 1navitoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Expanded_access × Primary Myelofibrosis × Myeloid × Clear all
NCT07215832 2026-03-02

KEAP

Karyopharm Therapeutics Inc

Available
GynecologicLymphoidMyeloidPlasma cellSarcoma

Multiple Myeloma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Endometrial Neoplasms, Primary Myelofibrosis

NCT04745637 2025-11-18

Managed Access Programs for INC424, Ruxolitinib

Novartis

Available
Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT03592576 2024-05-06

Expanded Access to Navitoclax

AbbVie

No longer available
LymphoidMyeloidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡